Fig 1: Effect of cyclophosphamide (CPA) with or without amentoflavone (AMV) on the levels of TGF-β1, NF-κB (p65), JAK2, and STAT3 in the pulmonary tissues (mean ± SEM). a Significant compared vs. the control group; b significant compared vs. the CPA group; and c significant compared vs. the CPA + AMV 50 mg/kg group.
Fig 2: PLA and AgRP increase lean mass content, improve in vivo muscle function and femoral bone strength in Ctns −/− mice. Twelve‐month‐old Ctns −/− and WT mice were administered with PLA, AgRP, or vehicle, respectively. Figures 3 and 4 describe detailed study procedures. Lean mass content of individual mice was measured using quantitative magnetic resonance analysis. In vivo muscle function (grip strength and rotarod) was assessed. Femoral shaft biomechanical tests were performed. Femur protein contents of JAK2 and STAT3 were measured. Data are expressed as mean ± SEM. Results were analysed and expressed as in Figures 3 and 4. Ns, not significant, *P < 0.05, **P < 0.01.
Supplier Page from Abcam for JAK2 ELISA Kit